Related Experiment Video

Updated: Jun 20, 2026

FIBS-enabled Noninvasive Metabolic Profiling
09:16

FIBS-enabled Noninvasive Metabolic Profiling

Published on: February 3, 2014

Site specific phosphorylation of insulin-like growth factor binding protein-1 (IGFBP-1) for evaluating clinical

Majida Abu Shehab1, Shinobu Inoue, Victor K M Han

  • 1Department of Pediatrics, University of Western Ontario, London, Ontario, Canada.

Journal of Proteome Research
|September 8, 2009
PubMed

Insights

Researchers developed a new method to enrich Insulin-like Growth Factor Binding Protein-1 (IGFBP-1) from amniotic fluid for analyzing its phosphorylation. This technique improves diagnostic potential for fetal growth restriction (FGR).

Area of Science:

  • Proteomics
  • Biochemistry
  • Reproductive Biology

Background:

  • Fetal growth restriction (FGR) is a major cause of fetal and neonatal complications.
  • Insulin-like Growth Factor Binding Protein-1 (IGFBP-1) phosphorylation is functionally relevant in FGR and holds diagnostic potential.
  • Accurate assessment of IGFBP-1 phosphorylation requires effective enrichment strategies from biological samples like amniotic fluid.

Purpose of the Study:

  • To develop and optimize a proteomic strategy for enriching IGFBP-1 from human amniotic fluid.
  • To enable the identification and assessment of IGFBP-1 phosphorylation sites for potential clinical applications in FGR.
  • To overcome limitations of existing enrichment methods, such as interference from other proteins and low recovery rates.

Main Methods:

  • Investigated immunoprecipitation using a monoclonal antibody (Mab 6303) against IGFBP-1, noting interference from co-enriched IgGs.
  • Employed covalent coupling of the antibody to resin and evaluated titanium dioxide (TiO(2)) for phosphopeptide enrichment.
  • Developed an albumin depletion strategy using Affi-Gel Blue gel, followed by LC-MS/MS analysis to assess IGFBP-1 phosphorylation sites.

Main Results:

  • Initial methods using immunoprecipitation and TiO(2) enrichment identified only a subset of expected IGFBP-1 phosphorylation sites (pSer101, pSer119).
  • Albumin depletion significantly improved IGFBP-1 recovery (approx. 68%) while reducing albumin levels (approx. 8.5%).
  • LC-MS/MS analysis of albumin-depleted samples successfully identified all four expected IGFBP-1 phosphorylation sites, with quantitative differences noted for pSer169 and pSer98.

Conclusions:

  • A novel, simplified proteomic approach utilizing albumin depletion effectively enriches IGFBP-1 from amniotic fluid for phosphorylation site analysis.
  • This strategy facilitates the identification of site-specific changes in IGFBP-1 phosphorylation, crucial for FGR research.
  • The developed method provides a vital tool for differential IGFBP-1 phosphorylation profiling in clinical settings, aiding FGR diagnostics and understanding fetal growth regulation.

More Related Videos

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...